Benign lymphoepithelial lesion of the lacrimal gland and its relationship to Sjögren's syndrome.
Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal gland.
Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland.
Evaluation of the Efficacy of Immune and Inflammatory Markers in the Diagnosis of Lacrimal-Gland Benign Lymphoepithelial Lesion.
Luan F, Liu R, Li J, Ge X, Wang N, Guo Q, Tao Y, Ma J.
Curr Issues Mol Biol. 2023 Mar 1;45(3):2013-2020. doi: 10.3390/cimb45030129.
Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance.
Zhang XJ, Zhao PX, Ma MS, Wu H, Liu R, Wang H, Liu MY, Xie F, Ma XM.
Int J Ophthalmol. 2023 Nov 18;16(11):1734-1745. doi: 10.18240/ijo.2023.11.02. eCollection 2023.
Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland.
Li QJ, Zhao PX, Zhang XJ, Yi Y, Cheng DY, Ma JM, Ma XM.
Int J Ophthalmol. 2017 Aug 18;10(8):1229-1232. doi: 10.18240/ijo.2017.08.07. eCollection 2017.
Clinical research on benign lymphoepithelial lesions of lacrimal gland in 20 Chinese patients.
Ma JM, Li J, Ge X, Li M, Li JR, Wang XN.
Chin Med J (Engl). 2015 Feb 20;128(4):493-8. doi: 10.4103/0366-6999.151102.
Different serum levels of IgG and complements and recurrence rates in IgG4-positive and negative lacrimal gland benign lymphoepithelial lesion.
Liu R, Wang N, Wang JJ, Li J, Ge X, Zhang JX, Ma JM.
Int J Ophthalmol. 2023 Jun 18;16(6):876-883. doi: 10.18240/ijo.2023.06.07. eCollection 2023.
Association of TCR-signaling pathway with the development of lacrimal gland benign lymphoepithelial lesions.
Ma JM, Cui YX, Ge X, Li J, Li JR, Wang XN.
Int J Ophthalmol. 2015 Aug 18;8(4):685-9. doi: 10.3980/j.issn.2222-3959.2015.04.08. eCollection 2015.
Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal gland.
Adzavon YM, Zhao P, Ma J, Zhang X, Zhang X, Zhang M, Liu M, Wang L, Chen D, Abisso TG, Lv B, Wang L, Xie F, Ma X.
Cell Commun Signal. 2018 Oct 22;16(1):70. doi: 10.1186/s12964-018-0284-4.
B cell receptor signaling pathway involved in benign lymphoepithelial lesions of the lacrimal gland.
Wang XN, Ge X, Li J, Liu X, Ma JM.
Int J Ophthalmol. 2017 May 18;10(5):665-669. doi: 10.18240/ijo.2017.05.01. eCollection 2017.
Complement System in the Pathogenesis of Benign Lymphoepithelial Lesions of the Lacrimal Gland.
Li J, Ge X, Wang X, Liu X, Ma J.
PLoS One. 2016 Feb 5;11(2):e0148290. doi: 10.1371/journal.pone.0148290. eCollection 2016.
The FcepsilonRI signaling pathway is involved in the pathogenesis of lacrimal gland benign lymphoepithelial lesions as shown by transcriptomic analysis.
Li J, Liu R, Sun M, Wang J, Wang N, Zhang X, Ge X, Ma J.
Sci Rep. 2021 Nov 8;11(1):21853. doi: 10.1038/s41598-021-01395-z.
